[Federal Register Volume 62, Number 249 (Tuesday, December 30, 1997)]
[Notices]
[Pages 67901-67902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33841]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Agency Information Collection Activities Extension of a Currently 
Approved Collection; Comment Request

ACTION: Application for Procurement Quota for Controlled Substances.

-----------------------------------------------------------------------

    The information collection is published to obtain comments from the 
public and affected agencies. Comments are encouraged and will be 
accepted until March 2, 1998.
    We are requesting written comments and suggestions from the public 
and affected agencies concerning the collection of information. Your 
comments should address one or more of the following four points:
    1. Evaluate whether the collection of information is necessary for 
the proper performance of the functions of the agency, including 
whether the information will have practical utility;
    2. Evaluate the accuracy of the agencies estimate of the burden of 
the collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    Comments and/or suggestions regarding the item(s) contained in this 
notice, especially regarding the estimated public burden and associated 
response time should be directed to Mr. Frank Sapienza, 202-307-7183, 
Chief, Drug and Chemical Evaluation Section, Office of Diversion 
Control, Drug Enforcement Administration, Washington, DC 20537. If you 
have additional comments, suggestions, or need a copy of the 
information collection instrument with instructions, or additional 
information, please contact Mr. Frank Sapienza.
    Additionally, comments may also be submitted to the Department of 
Justice (DOJ), Justice Management Division, Information Management and 
Security Staff, Attention: Department Clearance Officer, Suite 850, 
Washington Center, 1001 G Street, NW., Washington, DC 20530. Additional 
comments may be submitted to DOJ via facsimile at 202-514-1590.
    Overview of this information collection:
    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Procurement Quota 
for Controlled Substances. Agency form number: DEA Form 250; Applicable 
component of the Department of Justice sponsoring the collection: 
Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    3. Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Business or other for-profit. Other: 
None.
    Title 21, CFR, 1303.12 requires registered dosage form 
manufacturers who wish to purchase controlled substances in Schedule II 
to apply on DEA Form 250 for procurement quotas which limit purchase 
quantities. The information collected is used for establishing quotas 
and controlling procurement thereof.
    4. An estimate of the total estimated number of respondents and the 
amount of time estimated for an average respondent to respond: 531 
respondents at 1 response per year at 1 hour per response.

[[Page 67902]]

    5. An estimate of the total public burden (in hours) associated 
with the collection: 531 annual burden hours.
    Public comment on this proposed information collection is strongly 
encouraged.

    Dated: December 22, 1997.
Robert B. Briggs,
Department Clearance Officer, United States Department of Justice.
[FR Doc. 97-33841 Filed 12-29-97; 8:45 am]
BILLING CODE 4410-09-M